Skip to main content
Top

Clinical & Experimental Metastasis

Issue 8/2010

Content (8 Articles)

Research Paper

Serum follistatin in patients with prostate cancer metastatic to the bone

Francesca Maria Tumminello, Giuseppe Badalamenti, Fabio Fulfaro, Lorena Incorvaia, Marilena Crescimanno, Carla Flandina, Maria Vittoria Sepporta, Gaetano Leto

Research Paper

Involvement of Hepatopoietin Cn in the development of human hepatocellular carcinoma

Bu-Dong Zhu, Xiao-Li Li, Yong Liu, Jing Chang, Yang Liu, Dong-Dong Zhang, Qiang Wang, Jun Ren, Chun-Ping Cui

Research Paper

KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model

Lacey R. McNally, Danny R. Welch, Benjamin H. Beck, Lewis J. Stafford, Joshua W. Long, Jeffery C. Sellers, Zhi Q. Huang, William E. Grizzle, Cecil R. Stockard, Kevin T. Nash, Donald J. Buchsbaum

Research Paper

Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator

Eun-Yi Moon, Yun-Sun Im, Yun-Kyoung Ryu, Joo-Hyun Kang

Research Paper

p-AKT overexpression in primary renal cell carcinomas and their metastases

Martina Hager, Heike Haufe, Lukas Lusuardi, Nikolaus Schmeller, Christian Kolbitsch

Research Paper

Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8

Yoshihiro Yui, Kazuyuki Itoh, Kiyoko Yoshioka, Norifumi Naka, Motonobu Watanabe, Yoshimi Hiraumi, Hiroshi Matsubara, Ken-ichiro Watanabe, Kazumi Sano, Tatsutoshi Nakahata, Souichi Adachi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine